EP Patent

EP4091606A1 — A solid nanoparticle with inorganic coating

Assigned to Nanexa AB · Expires 2022-11-23 · 3y expired

What this patent protects

A nanoparticle having a solid core comprising a biologically active substance, said core being enclosed by an inorganic coating, a method for preparing the nanoparticle, and the use of the nanoparticle in therapy. A kit comprising the nanoparticle and a pharmaceutical composition…

USPTO Abstract

A nanoparticle having a solid core comprising a biologically active substance, said core being enclosed by an inorganic coating, a method for preparing the nanoparticle, and the use of the nanoparticle in therapy. A kit comprising the nanoparticle and a pharmaceutical composition comprising the nanoparticle.

Drugs covered by this patent

Patent Metadata

Patent number
EP4091606A1
Jurisdiction
EP
Classification
—
Expires
2022-11-23
Drug substance claim
No
Drug product claim
No
Assignee
Nanexa AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.